917357-83-6 Usage
Uses
Used in Organic Synthesis:
3-(Methylamino)-1-pyrrolidinecarboxylic acid benzyl ester is used as a versatile building block in organic synthesis for the creation of various drug molecules and bioactive compounds. Its unique structure and functional groups allow for easy modification, enhancing its utility in the synthesis process.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 3-(Methylamino)-1-pyrrolidinecarboxylic acid benzyl ester is utilized as an intermediate in the production of pharmaceuticals. Its structural features make it a promising candidate for the development of new drugs and therapeutic agents.
Used in Pharmaceutical Applications:
Due to its structural resemblance to certain biologically active molecules, 3-(Methylamino)-1-pyrrolidinecarboxylic acid benzyl ester may have potential pharmaceutical applications. Its presence in the development of new drugs could lead to advancements in treating various medical conditions.
Used in Research and Development:
3-(Methylamino)-1-pyrrolidinecarboxylic acid benzyl ester is also used in research and development settings to explore its potential applications and properties. Scientists and researchers leverage its unique characteristics to investigate new methods of drug synthesis and to understand its interactions with biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 917357-83-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,3,5 and 7 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 917357-83:
(8*9)+(7*1)+(6*7)+(5*3)+(4*5)+(3*7)+(2*8)+(1*3)=196
196 % 10 = 6
So 917357-83-6 is a valid CAS Registry Number.
InChI:InChI=1/C13H18N2O2/c1-14-12-7-8-15(9-12)13(16)17-10-11-5-3-2-4-6-11/h2-6,12,14H,7-10H2,1H3
917357-83-6Relevant academic research and scientific papers
INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1
-
Page/Page column 29, (2010/11/25)
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salts or solvates thereof, wherein n, X, Y, R1, R2, R3 and R4 are as described in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating conditions that are mediated by the modulation of 11 βHSD1 , the method comprising administering to a mammal an effective amount of a compound of formula (I).
